108 related articles for article (PubMed ID: 21681808)
1. Licofelone-nitric oxide donors as anticancer agents.
Liu W; Zhou J; Liu Y; Liu H; Bensdorf K; Guo C; Gust R
Arch Pharm (Weinheim); 2011 Aug; 344(8):487-93. PubMed ID: 21681808
[TBL] [Abstract][Full Text] [Related]
2. Investigations on cytotoxicity and anti-inflammatory potency of licofelone derivatives.
Liu W; Zhou J; Bensdorf K; Zhang H; Liu H; Wang Y; Qian H; Zhang Y; Wellner A; Rubner G; Huang W; Guo C; Gust R
Eur J Med Chem; 2011 Mar; 46(3):907-13. PubMed ID: 21295381
[TBL] [Abstract][Full Text] [Related]
3. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.
Moharram S; Zhou A; Wiebe LI; Knaus EE
J Med Chem; 2004 Mar; 47(7):1840-6. PubMed ID: 15027876
[TBL] [Abstract][Full Text] [Related]
5. Novel antileukemic agents derived from tamibarotene and nitric oxide donors.
Bian H; Feng J; Li M; Xu W
Bioorg Med Chem Lett; 2011 Dec; 21(23):7025-9. PubMed ID: 22014829
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel pyrrolopyrrolizinones as anticancer agents.
Rochais C; Lisowski V; Dallemagne P; Rault S
Bioorg Med Chem; 2006 Dec; 14(24):8162-75. PubMed ID: 17011196
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiproliferative activity of 2,4-disubstituted 6-aryl-7H-pyrrolo[3,2-d]pyrimidin-7-one 5-oxides.
Pudziuvelyte E; Ríos-Luci C; León LG; Cikotiene I; Padrón JM
Bioorg Med Chem; 2009 Jul; 17(14):4955-60. PubMed ID: 19527934
[TBL] [Abstract][Full Text] [Related]
8. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization and cytotoxicity of some novel 1,3-disubstituted-2,3-dihydro-2-iminobenzimidazoles.
Mavrova ATs; Wesselinova D; Vassilev N; Tsenov JA
Eur J Med Chem; 2011 Aug; 46(8):3362-7. PubMed ID: 21605925
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological activities of transition metal complexes based on acetylsalicylic acid as neo-anticancer agents.
Rubner G; Bensdorf K; Wellner A; Kircher B; Bergemann S; Ott I; Gust R
J Med Chem; 2010 Oct; 53(19):6889-98. PubMed ID: 20857911
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.
Naimi E; Zhou A; Khalili P; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
J Med Chem; 2003 Mar; 46(6):995-1004. PubMed ID: 12620076
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative activity of new cytotoxic azanaphthoquinone pyrrolo-annelated derivatives: Part II.
Shanab K; Schirmer E; Wulz E; Weissenbacher B; Lassnig S; Slanz R; Fösleitner G; Holzer W; Spreitzer H; Schmidt P; Aicher B; Müller G; Günther E
Bioorg Med Chem Lett; 2011 May; 21(10):3117-21. PubMed ID: 21458262
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates.
Banekovich C; Ott I; Koch T; Matuszczak B; Gust R
Bioorg Med Chem Lett; 2007 Feb; 17(3):683-7. PubMed ID: 17110105
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities.
Kumar A; Ahmad I; Chhikara BS; Tiwari R; Mandal D; Parang K
Bioorg Med Chem Lett; 2011 Mar; 21(5):1342-6. PubMed ID: 21300544
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and cytotoxic activity of nitric oxide-releasing isosteviol derivatives.
Wang TT; Liu Y; Chen L
Bioorg Med Chem Lett; 2014 May; 24(9):2202-5. PubMed ID: 24685545
[TBL] [Abstract][Full Text] [Related]
17. In vitro metabolism of 2-[6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl] acetic acid (licofelone, ML3000), an inhibitor of cyclooxygenase-1 and -2 and 5-lipoxygenase.
Albrecht W; Unger A; Nussler AK; Laufer S
Drug Metab Dispos; 2008 May; 36(5):894-903. PubMed ID: 18268076
[TBL] [Abstract][Full Text] [Related]
18. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
19. Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells.
Noratto G; Porter W; Byrne D; Cisneros-Zevallos L
J Agric Food Chem; 2009 Jun; 57(12):5219-26. PubMed ID: 19530711
[TBL] [Abstract][Full Text] [Related]
20. Licofelone, a dual COX/5-LOX inhibitor, induces apoptosis in HCA-7 colon cancer cells through the mitochondrial pathway independently from its ability to affect the arachidonic acid cascade.
Tavolari S; Bonafè M; Marini M; Ferreri C; Bartolini G; Brighenti E; Manara S; Tomasi V; Laufer S; Guarnieri T
Carcinogenesis; 2008 Feb; 29(2):371-80. PubMed ID: 18033773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]